Cargando…
A cell-permeant peptide corresponding to the cUBP domain of USP5 reverses inflammatory and neuropathic pain
BACKGROUND: Cav3.2 T-type calcium currents in primary afferents are enhanced in various painful pathological conditions, whereas inhibiting Cav3.2 activity or expression offers a strategy for combating the development of pain hypersensitivity. We have shown that Cav3.2 channel surface density is str...
Autores principales: | Garcia-Caballero, Agustin, Gadotti, Vinicius M, Chen, Lina, Zamponi, Gerald W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4955966/ https://www.ncbi.nlm.nih.gov/pubmed/27130589 http://dx.doi.org/10.1177/1744806916642444 |
Ejemplares similares
-
Small organic molecule disruptors of Cav3.2 - USP5 interactions reverse inflammatory and neuropathic pain
por: Gadotti, Vinicius M, et al.
Publicado: (2015) -
Cellular prion protein protects from inflammatory and neuropathic pain
por: Gadotti, Vinicius M, et al.
Publicado: (2011) -
Disrupting USP5/Cav3.2 interactions protects female mice from mechanical hypersensitivity during peripheral inflammation
por: Gadotti, Vinicius M., et al.
Publicado: (2018) -
Identification of interleukin-1 beta as a key mediator in the upregulation of Cav3.2–USP5 interactions in the pain pathway
por: Stemkowski, Patrick L, et al.
Publicado: (2017) -
The terpenes camphene and alpha-bisabolol inhibit inflammatory and neuropathic pain via Cav3.2 T-type calcium channels
por: Gadotti, Vinicius M., et al.
Publicado: (2021)